Explore

Rapid Read Rapid Read
PRSS56 Gene Identified as Key Target for Myopia Treatment

PRSS56 Gene Identified as Key Target for Myopia Treatment

Recent studies have highlighted the PRSS56 gene as a significant factor in the development of myopia, a condition characterized by excessive axial elongation of the eye. Research conducted by Wu et al. has identified two non-coding variants in PRSS56 that are associated with high myopia in affected individuals. These findings were derived from molecular genetic analyses of multigenerational pedigrees and supported by evidence from mouse models and in vitro systems. The study suggests that increased expression of PRSS56 may lead to axial elongation, making it a potential therapeutic target for myopia treatment. This discovery opens new avenues for developing treatments that could prevent or slow the progression of myopia, which is prevalent among young adults worldwide.
Trendline Trendline
Clear Mascara Gains Popularity for Its Versatile and Gentle Benefits

Clear Mascara Gains Popularity for Its Versatile and Gentle Benefits

Clear Mascara Gains Popularity for Its Versatile and Gentle Benefits
Rapid Read Rapid Read
Cao Fei's Dash Exhibition at Fondazione Prada Explores Agricultural Transformation

Cao Fei's Dash Exhibition at Fondazione Prada Explores Agricultural Transformation

Cao Fei's Dash exhibition has opened at Fondazione Prada in Milan, showcasing a multimedia installation that combines video, photography, virtual reality, documentary footage, and archival material. The exhibition, developed over three years, documents the transformation of agriculture through emerging technologies across rural regions in China and Southeast Asia. It features large-scale installations and image-based works that examine automated farming systems, data-driven processes, and changing labor conditions in agricultural landscapes. The exhibition is installed within the Podium at Fondazione Prada's Milan venue, occupying a central exhibition space across multiple levels. It includes constructed environments such as agricultural stations, storage structures, and simulated field conditions integrated with digital interfaces. The exhibition runs from April 9 to September 28, 2026, as part of the institution's annual program of contemporary art presentations.
Rapid Read Rapid Read
Cao Fei's Dash Exhibition Explores Agricultural Transformation at Fondazione Prada

Cao Fei's Dash Exhibition Explores Agricultural Transformation at Fondazione Prada

Cao Fei's Dash exhibition has opened at Fondazione Prada in Milan, showcasing a multimedia installation that combines video, photography, virtual reality, documentary footage, and archival material. The exhibition documents the transformation of agriculture through emerging technologies, developed over three years of research across rural regions in China and Southeast Asia. It features large-scale installations and image-based works that examine automated farming systems, data-driven processes, and changing labor conditions. The exhibition is installed within the Podium at Fondazione Prada, occupying a central exhibition space across multiple levels, and includes constructed environments such as agricultural stations and simulated field conditions integrated with digital interfaces.
Trendline Trendline
Datavault AI Announces Listing of Meme Coin Portfolio and RWA Token Suite on Biconomy Exchange

Datavault AI Announces Listing of Meme Coin Portfolio and RWA Token Suite on Biconomy Exchange

Datavault AI Announces Listing of Meme Coin Portfolio and RWA Token Suite on Biconomy Exchange
Rapid Read Rapid Read
Study Links Meat Consumption to Dementia Risk in Certain Genetic Profiles

Study Links Meat Consumption to Dementia Risk in Certain Genetic Profiles

A study published in JAMA Network Open has found a potential link between meat consumption and dementia risk, specifically in individuals with certain genetic profiles. Conducted as part of the Swedish National Study on Ageing and Care, the research analyzed data from over 2,000 older adults. It found that those with the APOE 3/4 and APOE 4/4 genotypes who consumed less meat had a higher risk of dementia compared to those with higher meat intake. This association was not observed in individuals without these genotypes. The study suggests that while processed red meat is generally linked to higher dementia risk, unprocessed meat might have protective effects for those with specific genetic predispositions.
AP News AP News
China’s exports grew 2.5% in March in a sharp slowdown as Iran war raises uncertainty

China’s exports grew 2.5% in March in a sharp slowdown as Iran war raises uncertainty

China’s exports grew 2.5% in March from a year ago, significantly slowing from the previous two months as uncertainties rose from the Iran war and its impact on energy prices and global demand
Rapid Read Rapid Read
Pinglu Canal to Enhance ASEAN-China Manufacturing Connectivity

Pinglu Canal to Enhance ASEAN-China Manufacturing Connectivity

The Pinglu Canal in China is nearing completion and is expected to open by the end of 2026. This 134km inland waterway in Guangxi will significantly enhance manufacturing links between China and ASEAN countries by reducing inland shipping costs and improving access. The canal will provide southwestern Chinese provinces with a shorter maritime route to the South China Sea, cutting transit times and logistics costs. This development is expected to strengthen supply-chain integration, particularly benefiting manufacturers in Vietnam, Thailand, and Malaysia. The canal will also facilitate the flow of raw materials into China's industrial regions, supporting sectors like electric vehicle production and tire manufacturing.
Trendline Trendline
Johnson Johnson Presents New Clinical Data for TECNIS PureSee IOL at ASCRS 2026

Johnson Johnson Presents New Clinical Data for TECNIS PureSee IOL at ASCRS 2026

Johnson Johnson Presents New Clinical Data for TECNIS PureSee IOL at ASCRS 2026
Rapid Read Rapid Read
SS-31 Peptide Investigated for Eye Health Amid Skepticism

SS-31 Peptide Investigated for Eye Health Amid Skepticism

The SS-31 peptide, also known as elamipretide, is gaining attention for its potential effects on eye health, particularly age-related macular degeneration (AMD). Despite claims on social media platforms like TikTok that SS-31 can improve eyesight, experts remain skeptical. The peptide is FDA-approved for treating Barth syndrome, a rare mitochondrial disease, but not for vision problems. Research into its effectiveness for AMD is ongoing, with initial studies showing ineffectiveness. Eye doctors emphasize that SS-31 is not a general eyesight improver and does not address common vision issues like astigmatism or presbyopia.
Rapid Read Rapid Read
Research Identifies PP2A-B56α Suppression as Key Driver in NSCLC Progression

Research Identifies PP2A-B56α Suppression as Key Driver in NSCLC Progression

Recent research has highlighted the role of PP2A-B56α in the progression of non-small cell lung cancer (NSCLC), particularly in tumors with EGFR mutations. The study found that the expression of PP2A-B56α is significantly reduced in NSCLC tumors compared to normal tissue, correlating with decreased patient survival. PP2A-B56α is known to dephosphorylate the oncoprotein c-MYC, which is crucial for maintaining epithelial cell identity. The suppression of PP2A-B56α leads to increased cellular plasticity and the activation of epithelial-mesenchymal transition (EMT) gene programs, which are associated with cancer metastasis. The research involved analyzing primary NSCLC patient-derived cell lines and found that low PP2A-B56α expression is linked to poor prognosis and increased tumorigenic phenotypes.
Rapid Read Rapid Read
CorTec Receives FDA Breakthrough Designation for Brain-Computer Interface in Stroke Rehabilitation

CorTec Receives FDA Breakthrough Designation for Brain-Computer Interface in Stroke Rehabilitation

CorTec has been granted the 'Breakthrough Device Designation' by the US Food and Drug Administration (FDA) for its Brain Interchange system, a fully implantable brain-computer interface (BCI) aimed at aiding motor recovery in stroke patients. This designation is specifically for the use of direct cortical electrical stimulation to treat chronic stroke-related impairments, marking the first BCI globally to receive such recognition for stroke motor rehabilitation. The FDA's Breakthrough Device program is designed to expedite the development and review of technologies that may offer more effective treatment for life-threatening or irreversibly debilitating conditions. CorTec's system combines neural signal recording with adaptive stimulation in a closed-loop architecture, designed to interpret brain signals and deliver therapeutic stimulation to restore motor function. The platform is currently under evaluation in an FDA-approved investigational device exemption study at the University of Washington in Seattl...